Cabaletta Bio, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
CABA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2929 Arch Street, Suite 600, Philadelphia, PA

Insiders trading volume in the past year

Cabaletta Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
5AM Ventures V, L.P. 10%+ Owner $6.77M Nov 1, 2021
Gwendolyn Binder President, Science & Technology $407K -$992K -70.9% Mar 1, 2024
Mark Simon Director Jun 3, 2024
Richard C. Henriques Jr Director Jun 3, 2024
Shawn Tomasello Director Jun 3, 2024
Brian Daniels Director Jun 1, 2021
Arun Das Chief Business Officer Mar 1, 2024
David J. Chang Chief Medical Officer Mar 1, 2024
Anup Marda Chief Financial Officer Mar 1, 2024
Scott C. Brun Director Jun 3, 2024
Catherine Bollard Director Jun 3, 2024
Steven Nichtberger President & CEO, Director Mar 1, 2024
Michael Gerard General Counsel Mar 1, 2024

Recent Insider Transactions by Companies or Individuals for Cabaletta Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.